Tamsulosin Hydrochloride Capsule
Product Images NDC 71335-1538

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71335-1538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351538)

Label for Tamsulosin Hydrochloride 0.4 mg capsules by Bryant Ranch Prepack. The label indicates a green/orange capsule, compares to Flomax 0.4 mg capsule by Alkem Laboratories. Includes storage instructions and a barcode, with package quantity of 30 capsules.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A line graph comparing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) under fasted and fed conditions. The graph shows concentration changes from 0 to 36 hours, with separate curves for fasted (dashed line) and fed (solid line) states.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

A line graph showing mean change over treatment duration in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The X-axis represents treatment duration from baseline to 13 weeks and an LOCF time point, with sample sizes noted. The Y-axis shows mean change values ranging from 0 to -10. Lines for 0.8 mg and 0.4 mg show a greater decrease compared to placebo over time.*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph depicting mean change over the duration of treatment in weeks for Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo groups. The x-axis represents treatment duration in weeks, and the y-axis shows mean change values. Data points are marked with circles, triangles, and squares for different treatment groups.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph illustrating mean changes in a measured variable over a duration of up to 13 weeks, comparing treatments of 0.8 mg, 0.4 mg, and placebo. The x-axis represents duration in weeks, and the y-axis represents mean change in mL/sec. Three separate lines correspond to the treatments, showing trends and differences over time.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

Line graph depicting mean change in urinary flow rate (mL/sec) over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg Tamsulosin Hydrochloride, and placebo. The graph shows data points at baseline, 1, 4, 7, 10, and 13 weeks with sample sizes indicated. Both Tamsulosin doses show greater improvement compared to placebo over time.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.